The effect of 3-hydroxybutyrate on the in vitro differentiation of murine osteoblast MC3T3-E1 and in vivo bone formation in ovariectomized rats

Biomaterials ◽  
2007 ◽  
Vol 28 (20) ◽  
pp. 3063-3073 ◽  
Author(s):  
Yan Zhao ◽  
Bing Zou ◽  
Zhenyu Shi ◽  
Qiong Wu ◽  
Guo-Qiang Chen
Spine ◽  
2018 ◽  
Vol 43 (11) ◽  
pp. E616-E624 ◽  
Author(s):  
Sadaaki Kanayama ◽  
Takashi Kaito ◽  
Kazuma Kitaguchi ◽  
Hiroyuki Ishiguro ◽  
Kunihiko Hashimoto ◽  
...  

2016 ◽  
Vol 30 ◽  
pp. 319-333 ◽  
Author(s):  
Patrina S.P. Poh ◽  
Dietmar W. Hutmacher ◽  
Boris M. Holzapfel ◽  
Anu K. Solanki ◽  
Molly M. Stevens ◽  
...  

2015 ◽  
Vol 11 (11) ◽  
pp. 1325-1336 ◽  
Author(s):  
Ruchi Mishra ◽  
Deepak Bushan Raina ◽  
Mea Pelkonen ◽  
Lars Lidgren ◽  
Magnus Tägil ◽  
...  

Gene Therapy ◽  
2021 ◽  
Author(s):  
Gileade P. Freitas ◽  
Helena B. Lopes ◽  
Alann T. P. Souza ◽  
Maria Paula O. Gomes ◽  
Georgia K. Quiles ◽  
...  

2002 ◽  
Vol 292 (1) ◽  
pp. 144-152 ◽  
Author(s):  
Kris Partridge ◽  
Xuebin Yang ◽  
Nicholas M.P. Clarke ◽  
Yasunori Okubo ◽  
Kazuhisa Bessho ◽  
...  

2016 ◽  
Vol 63 (2) ◽  
Author(s):  
Joanna Folwarczna ◽  
Maria Zych ◽  
Barbara Nowińska ◽  
Maria Pytlik ◽  
Magdalena Bialik ◽  
...  

Diosgenin is a steroidal sapogenin present in fenugreek and Dioscorea spp. as glycosides (saponins). Diosgenin has already been reported to inhibit osteoclastogenesis and to stimulate osteogenic activity of osteoblastic cells in vitro, and to exert some antiosteoporotic effects in rats in vivo. The aim of the present study was to investigate the effects of diosgenin administration on the skeletal system of rats with normal estrogen level and with estrogen deficiency induced by bilateral ovariectomy. The experiments were carried out on 3-month-old non-ovariectomized and ovariectomized Wistar rats, divided into control rats and rats receiving diosgenin (50 mg/kg p.o. daily) for 4 weeks. Serum bone turnover markers, bone mass and mineralization, histomorphometric parameters and mechanical properties were studied. Diosgenin improved some investigated parameters in both non-ovariectomized and ovariectomized rats, in which estrogen deficiency induced osteoporotic changes. Diosgenin increased compact bone formation and probably inhibited cancellous bone resorption, which led to improvement of mechanical properties of compact and cancellous bone. In conclusion, this in vivo study demonstrated that diosgenin may be one of sparse compounds increasing bone formation.


2017 ◽  
Vol 57 ◽  
pp. 511-523 ◽  
Author(s):  
Winston A. Camargo ◽  
Shinji Takemoto ◽  
Jan Willem Hoekstra ◽  
Sander C.G. Leeuwenburgh ◽  
John A. Jansen ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document